Drug recall D-1232-2020
Product
Gabapentin Capsules, USP 100mg 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-198-99
Reason for recall
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Lots and codes
Lot #: 198180048A, Exp. Date 04/2021; 198180061A, Exp. Date 06/2020; 19819017A1, Exp. Date 02/2021
Recall details
- Recalling firm
- Aurobindo Pharma USA Inc., East Windsor, NJ
- Quantity
- 26625 units
- Distribution
- Nationwide within the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 18, 2020
- Terminated
- March 25, 2024
Related products
- Gabapentin – drug information
- NDC 65862-198 Gabapentin · Gabapentin 100 mg/1 · Aurobindo Pharma Limited
- NDC 65862-200 Gabapentin · Gabapentin 400 mg/1 · Aurobindo Pharma Limited
- NDC 65862-199 Gabapentin · Gabapentin 300 mg/1 · Aurobindo Pharma Limited